Metraipolis › archive › dc_c8e2ad10ee43

Erucin Targets Oncogenic Signaling Pathways in Triple-Negative Breast Cancer: An Integrated Network Pharmacology and In Vitro Study — Europe PMC PMID:42195263

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42195263
DOI
10.3390/life16050708
License (as archived)
solo-consultazione
Archived
2026-11-01T07:32:22.887Z
SHA-256 of the archived text
df4db27a5e41f346ce0bb5b99a60eab8557973b714988c96dc18c3e8d1b51a3e
Stable URL of this page
https://metraipolis.com/documento/dc_c8e2ad10ee43

How to cite

Erucin Targets Oncogenic Signaling Pathways in Triple-Negative Breast Cancer: An Integrated Network Pharmacology and In Vitro Study — Europe PMC PMID:42195263 — Europe PMC (en), https://europepmc.org/article/MED/42195263 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c8e2ad10ee43 (Metraipolis archive dc_c8e2ad10ee43, sha256 df4db27a5e41f346ce0bb5b99a60eab8557973b714988c96dc18c3e8d1b51a3e)
BibTeX
@misc{dcc8e2ad10ee43,
  title = {Erucin Targets Oncogenic Signaling Pathways in Triple-Negative Breast Cancer: An Integrated Network Pharmacology and In Vitro Study — Europe PMC PMID:42195263},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42195263},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c8e2ad10ee43; sha256 df4db27a5e41f346ce0bb5b99a60eab8557973b714988c96dc18c3e8d1b51a3e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42195263. Agents can read the archived copy with the MCP tool read_document.